Valeritas’ V-Go Shows Significant Benefits Compared to Conventional Insulin Delivery in Patients with Type 2 Diabetes

Valeritas VGo
Valeritas V-Go® Wearable Insulin Delivery device has been found to be beneficial compared to conventional insulin delivery in patients with type 2 diabetes. In a study published in the journal […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleInsider Navigation-AR Automation Partnering Up to Bring AR into the Vertical Farming Industry
Next articleSingapore’s Changi Airport Construction Site Using Smartglasses and other technology for Safety and Security Measures
Ramona Socher is Online Editor at WT | Wearable Technologies